• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁缺乏导致p53表达增加。

Iron deprivation results in an increase in p53 expression.

作者信息

Fukuchi K, Tomoyasu S, Watanabe H, Kaetsu S, Tsuruoka N, Gomi K

机构信息

Department of Clinical Pathology, Showa University, Tokyo, Japan.

出版信息

Biol Chem Hoppe Seyler. 1995 Oct;376(10):627-30. doi: 10.1515/bchm3.1995.376.10.627.

DOI:10.1515/bchm3.1995.376.10.627
PMID:8590632
Abstract

Deferoxamine (DFO)-induced iron deprivation caused an increase in p53 expression in ML-1 and Raji cells. In ML-1 cells, with express wild type p53, p53 protein levels were transiently increased 6 h after addition of 10(-4)M DFO. In Raji cells, which carry a mutant p53 allele, p53 increased 6 h after addition of 10(-4)M DFO and remained elevated for 24 h. Growth inhibition was observed in both cell types 6 h after addition of 10(-4)M DFO. In both cells, p53 mRNA levels did not increase following incubation with DFO, suggesting that increased p53 expression is the result of a post-transcriptional mechanism. Although increases in wild type p53 protein in ML-1 cells resulted in increases in a p53 target gene, p21cipl/wafl/sdil, this effect was not observed in Raji cells which express a mutant p53 protein.

摘要

去铁胺(DFO)诱导的铁缺乏导致ML-1和Raji细胞中p53表达增加。在表达野生型p53的ML-1细胞中,加入10⁻⁴M DFO后6小时,p53蛋白水平短暂升高。在携带突变p53等位基因的Raji细胞中,加入10⁻⁴M DFO后6小时p53升高,并持续升高24小时。加入10⁻⁴M DFO后6小时,两种细胞类型均观察到生长抑制。在两种细胞中,与DFO孵育后p53 mRNA水平未增加,表明p53表达增加是转录后机制的结果。尽管ML-1细胞中野生型p53蛋白的增加导致p53靶基因p21cipl/wafl/sdil增加,但在表达突变p53蛋白的Raji细胞中未观察到这种效应。

相似文献

1
Iron deprivation results in an increase in p53 expression.铁缺乏导致p53表达增加。
Biol Chem Hoppe Seyler. 1995 Oct;376(10):627-30. doi: 10.1515/bchm3.1995.376.10.627.
2
Iron deprivation-induced apoptosis in HL-60 cells.铁缺乏诱导HL-60细胞凋亡。
FEBS Lett. 1994 Aug 15;350(1):139-42. doi: 10.1016/0014-5793(94)00755-1.
3
G1 accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells.
Biochim Biophys Acta. 1997 Jul 24;1357(3):297-305. doi: 10.1016/s0167-4889(97)00040-2.
4
Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.铁螯合剂对人神经母细胞瘤细胞中N-myc表达的抑制及凋亡诱导作用
Cancer Res. 2001 Feb 1;61(3):1073-9.
5
[Effect of desferrioxamine on K562/A02 cell line and its mechanism].去铁胺对K562/A02细胞系的作用及其机制
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Apr;19(2):337-41.
6
Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells.去铁胺刺激HepG2细胞中低密度脂蛋白受体(LDLR)的表达及低密度脂蛋白(LDL)摄取。
Mol Nutr Food Res. 2016 Mar;60(3):600-8. doi: 10.1002/mnfr.201500467. Epub 2015 Dec 9.
7
Effects of Deferoxamine on Leukemia In Vitro and Its Related Mechanism.去铁胺对白血病的体外作用及其相关机制。
Med Sci Monit. 2018 Sep 24;24:6735-6741. doi: 10.12659/MSM.910325.
8
Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes.铁螯合剂诱导永生化及恶性口腔角质形成细胞生长停滞和细胞色素c依赖性凋亡。
J Oral Pathol Med. 2006 Apr;35(4):218-26. doi: 10.1111/j.1600-0714.2006.00415.x.
9
Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.腺病毒介导的p53基因递送增强野生型p53人胶质瘤细胞的放射敏感性
J Neurosurg. 1998 Jul;89(1):125-32. doi: 10.3171/jns.1998.89.1.0125.
10
HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation.铁螯合作用通过HIF-1介导转铁蛋白受体基因转录的激活。
Nucleic Acids Res. 1999 Nov 1;27(21):4223-7. doi: 10.1093/nar/27.21.4223.

引用本文的文献

1
Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.铁螯合剂通过破坏细胞内铁稳态和激活 MAPK 通路诱导骨肉瘤细胞凋亡。
Int J Mol Sci. 2021 Jul 2;22(13):7168. doi: 10.3390/ijms22137168.
2
Reversing oncogenic transformation with iron chelation.用铁螯合剂逆转致癌转化。
Oncotarget. 2021 Jan 19;12(2):106-124. doi: 10.18632/oncotarget.27866.
3
Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment.铁耗竭加埃博霉素对乳腺癌微环境的抑制作用。
BMC Cancer. 2020 Dec 10;20(1):1215. doi: 10.1186/s12885-020-07673-9.
4
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells.地拉罗司依赖的铁螯合作用通过稳定白血病细胞中的 p53 家族成员增强线粒体功能障碍和恢复 p53 信号转导。
Int J Mol Sci. 2020 Oct 16;21(20):7674. doi: 10.3390/ijms21207674.
5
Prognostic associations of plasma hepcidin in women with early breast cancer.早期乳腺癌女性血浆铁调素的预后相关性
Breast Cancer Res Treat. 2020 Dec;184(3):927-935. doi: 10.1007/s10549-020-05903-z. Epub 2020 Sep 22.
6
Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes.多胺和铁代谢途径在细胞增殖调控中的偶联:对关键多胺生物合成和分解代谢酶改变的机制联系。
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2793-2813. doi: 10.1016/j.bbadis.2018.05.007. Epub 2018 May 16.
7
BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.新型抗肿瘤纳米复合物BCc1在体外和体内均显示出强大的抗癌作用。
Drug Des Devel Ther. 2015 Dec 30;10:59-70. doi: 10.2147/DDDT.S89694. eCollection 2016.
8
Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.在一系列肿瘤细胞类型中,具有抗增殖活性的螯合剂对细胞周期蛋白依赖性激酶抑制剂p21CIP1/WAF1的差异性靶向作用。
Oncotarget. 2015 Oct 6;6(30):29694-711. doi: 10.18632/oncotarget.5088.
9
Targeting cancer by binding iron: Dissecting cellular signaling pathways.通过结合铁靶向癌症:剖析细胞信号通路。
Oncotarget. 2015 Aug 7;6(22):18748-79. doi: 10.18632/oncotarget.4349.
10
Iron deprivation in cancer--potential therapeutic implications.癌症中的铁剥夺——潜在的治疗意义。
Nutrients. 2013 Jul 24;5(8):2836-59. doi: 10.3390/nu5082836.